Trial Profile
Open-label, two-period single sequence study investigating the effect of Ketoconazole on the pharmacokinetics of a single dose of alisporivir
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Alisporivir (Primary) ; Ketoconazole
- Indications Bacterial infections; Hepatitis C
- Focus Pharmacokinetics
- 30 Dec 2015 New trial record